Stanley Dawes Chamberlain

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Smithkline Beecham Corporation, Glaxo Wellcome Inc., Inhibitex, Inc.. Active years: 1999-2019.

USPTO Granted Patents = 20

% Patents Active = 55.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 169(Granted Patents)

Location History:

Research Triangle Park, NC (US) (2002)
Durham, NC (US) (2005 - 2009)
Alpharetta, GA (US) (2014)
Chapel Hill, NC (US) (1999 - 2019)

Company Filing History:

9 out of 2,198

Smithkline Beecham Corporation

Purthread Technologies, Inc.

patents

5. 2 out of 136

University College Cardiff Consultants Limited

7. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10508188 - Antimicrobial and antifungal polymer fibers, fabrics, and methods of manufacture thereof (2019-12-17),

2. 9908987 - Antimicrobial and antifungal polymer fibers, fabrics, and methods of manufacture thereof (2018-03-06),

3. 9351989 - Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections (2016-05-31),

4. 8759318 - Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections (2014-06-24),

5. 7981903 - 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer (2011-07-19),

6. 7491731 - Crystal structure of liganded cFMS kinase domain (2009-02-17),

7. 7338959 - Diamino-pyrimidines and their use as angiogenesis inhibitors (2008-03-04),

8. 7163940 - Pyrazolopyridinyl pyrimidine therapeutic compounds (2007-01-16),

9. 7160897 - Therapeutic compounds (2007-01-09),

10. 7109209 - Pyrazolopyridines, process for their preparation and use as therapeutic compounds (2006-09-19),

11. 7087618 - Pyrazolopyridinyl pyrimidine therapeutic compounds (2006-08-08),

12. 7034030 - Pyralopyridines, process for their preparation and use as therapeutic compounds (2006-04-25),

13. 6919352 - Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds (2005-07-19),

14. 6617315 - Therapeutic compounds (2003-09-09),

15. 6455507 - Benzimidazole derivatives (2002-09-24),

Title: The Legacy of Stanley Dawes Chamberlain

Introduction: Stanley Dawes Chamberlain, a distinguished inventor hailing from Durham, NC, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Chamberlain's latest patents include a revolutionary design for a solar-powered water purification system and a cutting-edge technology for sustainable energy storage.

Career Highlights: With a career spanning over two decades, Chamberlain has been at the forefront of technological advancements, holding multiple patents in renewable energy, environmental sustainability, and healthcare devices.

Collaborations: Throughout his career, Chamberlain has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life. His partnerships have led to the development of life-changing technologies that have impacted various industries.

Conclusion: Stanley Dawes Chamberlain's relentless pursuit of innovation and his passion for creating solutions to global challenges have solidified his position as a visionary inventor in the world of technology.